US Biopharma Chooses Thought Leader Select for KOL Initiatives in Lupus
December 4, 2013 (CHAPEL HILL, NC) Thought Leader Select, a consulting firm to the life sciences industries, is working with a U.S. biopharmaceutical company on key opinion leader (KOL) initiatives in systemic lupus. The client company, a leader in developing new medicines for difficult-to-treat auto-immune and inflammatory disorders, chose North Carolina’s Thought Leader Select to assist …
US Biopharma Chooses Thought Leader Select for KOL Initiatives in Lupus Read More »
